Drug Trial Radar · NCT05297201
Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients With Levodopa Induced Dyskinesia
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
105
Actual
Start
Nov 2, 2021
Primary completion
Jan 13, 2025
Study completion Jan 27, 2025
Sponsor
- Lead sponsor
- Celon Pharma SAIndustry
- Sponsor type
- Industry
- Collaborators
- National Center for Research and Development, Poland
- First posted
- Mar 28, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 50 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of the study is to determine potential anti-dyskinetic properties of CPL500036 (PDE10A inhibitor) in Parkinson disease patients suffering from levodopa Induced dyskinesia. The study is to determine the efficacy and dose response of two CPL500036 doses, compared with placebo.
Conditions
- Parkinson Disease
- Dyskinesia, Medication-Induced
Interventions
CPL500036 - low doseDrug
CPL500036 will be given orally. Each patient is to take 2 capsules with active substance and 2 capsules of placebo daily.
CPL500036 - high doseDrug
CPL500036 will be given orally. Each patient is to take 4 capsules with active substance daily.
PlaceboDrug
Placebo will be given orally. Each patient is to take 4 capsules of placebo daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Total UDysRS Score at Week 4.Time frame: Day -1, Day 28
Locations
16 sites in 2 countries. Site status is shown where the registry gives one.
Instytut Zdrowia dr Boczarska-Jedynak Sp. Z o.o., Sp. K.,
Oświęcim, Małopolska, Poland
Mazowiecki Szpital Bródnowski
Warsaw, Masovian Voivodeship, Poland
Cherkasy Regional Hospital of the Cherkasy Regional Council
Cherkasy, Ukraine
Ukrainian State Research Institute of Medical and Social Problems of Disability of the Ministry of Health of Ukraine, Department of Neurology and Borderline Conditions;
Dnipro, Ukraine
Treatment and Diagnostic Centre "Neuro Global" of the Limited Liability Company "Neuro Global", Treatment and Prevention Sub-division
Ivano-Frankivsk, Ukraine
Institute of Neurology, Psychiatry and Narcology of the Academy of Medical Sciences of Ukraine, Department of Vascular Pathology of the Brain and Rehabilitation
Kharkiv, Ukraine
"Medical center "Dobrobut-Polyclinic" "Medical diagnostic center "Dobrobut"
Kyiv, Ukraine
Medical Center of the Limited Liability Company "Medical Center "Consilium Medical"
Kyiv, Ukraine
"D.F. Chebotaryov Institute of Gerontology of the National Academy of Medical Sciences of Ukraine
Kyiv, Ukraine
Municipal non-profit enterprise of Lviv regional council "Lviv regional clinical hospital", Neurological Department
Lviv, Ukraine
Poltava Regional Clinical Hospital named after M.V. Sklifosovsky of the Poltava Regional Council
Poltava, Ukraine
Limited Liability Company, Medical Center "DIAMED"
Uzhhorod, Ukraine
Medical Center of the Limited Liability Company "Salyutem Medical Center"
Vinnytsy, Ukraine
"INET-09" LLC (Medical Center)
Zaporizhzhya, Ukraine
Educational and Scientific Medical Center "University Clinic" of Zaporizhzhia State Medical University
Zaporizhzhya, Ukraine
Communal Enterprise "Hospital" of Zhytomyr City Council
Zhytomyr, Ukraine
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.